Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


AI as a new paradigm for risk-based screening for breast cancer

AI may represent a new tool in the risk assessment and screening pathway of breast cancer. To realise its potential, the effect of AI-supported decisions on relevant clinical outcomes must be prospectively evaluated.

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: BC risk factors.


  1. Lauby-Secretan, B. et al. New Engl. J. Med. 372, 2353–2358 (2015).

    CAS  Article  Google Scholar 

  2. Esserman, J. J. et al. NPJ Breast Cancer 3, 34 (2017).

    Article  Google Scholar 

  3. Pashayan, N. et al. Nat. Rev. Clin. Oncol. 17, 687–705 (2020).

    Article  Google Scholar 

  4. Yala, A. et al. Nat. Med. (2021).

    Article  Google Scholar 

  5. Houssami, N. et al. Breast 38, 150–153 (2018).

    Article  Google Scholar 

  6. Trentham-Dietz, A. et al. Ann. Int. Med. 165, 700–712 (2016).

    Article  Google Scholar 

  7. Tice, J. A. et al. J. Clin. Oncol. 33, 3137–3143 (2015).

    Article  Google Scholar 

  8. Terry, M. B. et al. Lancet Oncol. 20, 504–517 (2019).

    Article  Google Scholar 

  9. Pal, C. P. et al. J. Natl Cancer Inst. 112, 278–285 (2020).

    Article  Google Scholar 

  10. Eriksson, M. et al. Radiology 297, 327–333 (2020).

    Article  Google Scholar 

  11. Kerlikowske, K. et al. J. Natl Cancer Inst. 113, 909–916 (2021).

    Article  Google Scholar 

  12. Aarts, A. et al. J. Med. Screen. 26, 147–153 (2019).

    Article  Google Scholar 

Download references


N.H. receives funding via the National Breast Cancer Foundation (NBCF) Chair in Breast Cancer Prevention grant (EC-21-001).

Author information

Authors and Affiliations



N.H. and K.K. contributed equally to this article.

Corresponding author

Correspondence to Nehmat Houssami.

Ethics declarations

Competing interests

N.H. is collaborating in evaluations of various AI algorithms for mammography screening. N.H. does not receive any funding or sponsorship from the AI industry, and is not involved in the development of AI systems.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Houssami, N., Kerlikowske, K. AI as a new paradigm for risk-based screening for breast cancer. Nat Med 28, 29–30 (2022).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing